McKesson Corporation logo

McKesson Corporation

MCK | NYSE
Chart Builder DCF Calculator
$886.47
+$11.82 (+1.35%)
At close: Sep 21, 2026, 4:00 PM ET
$886.60
+$0.13 (+0.01%)
After-hours: Sep 21, 2026, 7:01 PM ET

Company Profile

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Key Executives

Name Position
Brian S. Tyler CEO & Chairman
Francisco Fraga Executive Vice President, Chief Information Officer & Chief Technology Officer
Kenny K. Cheung Executive Vice President & Chief Financial Officer
Michele Lau Executive Vice President & Chief Legal Officer
Jeni Dominguez Head of Investor Relations
Kirk Kaminsky Executive Vice President & Group President of North American Pharmaceutical Services
LeAnn Smith Executive Vice President & Chief Human Resources Officer
Martin Koffel Executive Officer
Napoleon Rutledge Jr. Senior Vice President, Controller & Chief Accounting Officer
Paul A. Smith Senior Vice President of Taxes
Paula Adkison Senior Vice President of Corporate Finance, Investor Relations & Strategic Finance
Saralisa C. Brau Corporate Secretary
Stanton McComb President of Medical-Surgical
Thomas L. Rodgers Executive Vice President and Chief Strategy & Business Development Officer
Todd Kleinow VP of Strategic Distribution & Operations
Yiyi Frechette Director of Investor Relations

Latest SEC Filings

Date Type Title
Aug 28, 2026 8-K Current Report
Aug 11, 2026 4 Filing
Aug 11, 2026 4 Filing
Aug 10, 2026 3 Filing
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 24, 2026 8-K Current Report
Jul 23, 2026 4 Filing
Jul 23, 2026 4 Filing
Jul 23, 2026 4 Filing
View All SEC Filings
McKesson Corporation
McKesson Corporation logo
Country United States
IPO Date Nov 9, 1994
Industry Medical - Distribution
Sector Healthcare
Employees 42,300
CEO Brian S. Tyler

Contact Details

6555 State Highway 161 Irving, Texas 75039 United States

Stock Details

Ticker Symbol MCK
Exchange NYSE
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000927653
CUSIP Number 58155Q103
ISIN Number US58155Q1031
SIC Code 5122

© 2026 bestshares.com. All rights reserved.